Synapse - Fc-mediated antibody effector function, inflammation resolution and oligoclonality on TCR rearrangements predict sustained MRD negativity in newly diagnosed multiple myeloma treated with immunotherapy regimens

Fc-mediated antibody effector function, inflammation resolution and oligoclonality on TCR rearrangements predict sustained MRD negativity in newly diagnosed multiple myeloma treated with immunotherapy regimens Meeting Abstract

Authors:	Boyle, E. M.; Maura, F.; Coffey, D.; Maclachlan, K. H.; Diamond, B.; Ghamlouch, H.; Gagler, D.; Blaney, P.; Ziccheddu, B.; Wang, Y.; Guzman, E.; Tenenbaum, A.; Siegel, A.; Chen, X.; Varma, G.; Hoffman, J. E.; Kazandjian, D.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Tan, C.; Hultcrantz, M.; Scordo, M.; Shah, G. L.; Landau, H.; Chung, D. J.; Giralt, S. A.; Zhang, Y.; Dogan, A.; Lesokhin, A. M.; Verducci, D.; Davies, F. E.; Usmani, S.; Korde, N.; Landgren, O.; Morgan, G. J.
Abstract Title:	Fc-mediated antibody effector function, inflammation resolution and oligoclonality on TCR rearrangements predict sustained MRD negativity in newly diagnosed multiple myeloma treated with immunotherapy regimens
Meeting Title:	64th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	140
Issue:	Suppl. 1
Meeting Dates:	2022 Dec 10-13
Meeting Location:	New Orleans, LA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2022-11-15
Start Page:	249
End Page:	251
Language:	English
ACCESSION:	WOS:000893223200101
DOI:	10.1182/blood-2022-165500
PROVIDER:	wos
Notes:	Meeting Abstract -- Source: Wos